|
Volumn 35, Issue 12, 2010, Pages 1641-1643
|
Thought on several problems of clinical revaluationof post-marketing herb research
|
Author keywords
Herbs; Re evaluation of clinical postmarketing; Traditional Chinese medicine
|
Indexed keywords
EVALUATION;
GOVERNMENT REGULATION;
HERB;
LAW;
MARKETING;
MEDICAL RESEARCH;
NONHUMAN;
SHORT SURVEY;
ADVERSE DRUG REACTION;
CHINA;
DRUG THERAPY;
HUMAN;
POSTMARKETING SURVEILLANCE;
STANDARDS;
CHINA;
DRUG THERAPY;
DRUG TOXICITY;
DRUGS, CHINESE HERBAL;
HUMANS;
PRODUCT SURVEILLANCE, POSTMARKETING;
DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS;
HERBACEOUS AGENT;
|
EID: 77957086909
PISSN: 10015302
EISSN: None
Source Type: Journal
DOI: 10.4268/cjcmm20101230 Document Type: Short Survey |
Times cited : (2)
|
References (4)
|